Skip to main content
Midas Edge

VOLITIONRX LTD

For the period ended Sep 30, 2025. Filed Nov 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 13, 2025

VNRX$0.18-7.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders’ Deficit

Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited)

For the Three and Nine Months ended September 30, 2025 and September 30, 2024
Accumulated
Additional · Other · Non -
Common Stock · Paid-in · Comprehensive · Accumulated · Controlling
SharesAmountCapitalIncomeDeficitInterestTotal
#$$$$$$
Balance, December 31, 202496,097,48596,098204,154,994385,631(229,544,343)(1,200,116)(26,107,736)
Common stock issued for cash, net of issuance costs4,551,4294,5512,380,103---2,384,654
Common stock issued for settlement of RSUs97,55398(98)----
Stock-based compensation in relation to modification of options--103,573---103,573
Stock-based compensation--347,801---347,801
Tax withholdings paid related to stock-based compensation--(24,411)---(24,411)
Foreign currency translation---(253,929)--(253,929)
Net loss for the period----(5,423,759)(52,868)(5,476,627)
Balance, March 31, 2025100,746,467100,747206,961,962131,702(234,968,102)(1,252,984)(29,026,675)
Common stock issued for cash, net of issuance costs321,56232260,282---60,604
Common stock issued for cash, in respect of warrant shares1,958,2731,958----1,958
Common stock issued for settlement of RSUs955,718955(955)----
Issuance of warrants in connection with convertible note offering--1,998,869---1,998,869
Stock-based compensation--812,045---812,045
Tax withholdings paid related to stock-based compensation--(55,057)---(55,057)
Foreign currency translation---(575,996)--(575,996)
Net loss for the period----(6,284,078)(29,992)(6,314,070)
Balance, June 30, 2025103,982,020103,982209,777,146(444,294)(241,252,180)(1,282,976)(33,098,322)
Common stock issued for cash, net of issuance costs3,439,1563,4392,002,379---2,005,818
Common stock issued for cash, in respect of warrant shares1,599,0001,599----1,599
Common stock issued for settlement of RSUs600,229600(600)----
Stock-based compensation--609,167---609,167
Tax withholdings paid related to stock-based compensation--(80,381)---(80,381)
Foreign currency translation--22,348--22,348
Net loss for the period---(5,378,358)(31,433)(5,409,791)
Balance, September 30, 2025109,620,405109,620212,307,711(421,946)(246,630,538)(1,314,409)(35,949,562)

Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited)

For the Three and Nine Months ended September 30, 2025 and September 30, 2024
Accumulated
Additional · Other · Non -
Common Stock · Paid-in · Comprehensive · Accumulated · Controlling
SharesAmountCapitalIncome (Loss)DeficitInterestTotal
#$$$$$$
Balance, December 31, 202381,898,32181,898194,448,414243,940(202,576,507)(909,967)(8,712,222)
Common stock issued for cash, net of issuance costs13,3501315,721---15,734
Common stock issued for settlement of RSUs68,16969(69)----
Stock-based compensation--411,220---411,220
Tax withholdings paid related to stock-based compensation--(3,062)---(3,062)
Common stock issued in lieu of license fee129,132129125,129---125,258
Foreign currency translation---15,026--15,026
Net loss for the period----(8,367,388)(104,617)(8,472,005)
Balance, March 31, 202482,108,97282,109194,997,353258,966(210,943,895)(1,014,584)(16,620,051)
Common stock issued for cash, net of issuance costs734,155734588,754---589,488
Common stock issued for settlement of RSUs85,18785(85)----
Stock-based compensation--208,046---208,046
Tax withholdings paid related to stock-based compensation--(38,205)---(38,205)
Foreign currency translation---23,286--23,286
Net loss for the period----(6,985,546)(74,629)(7,060,175)
Balance, June 30, 202482,928,31482,928195,755,863282,252(217,929,441)(1,089,213)(22,897,611)
Issuance costs9,170,0009,1705,951,030---5,960,200
Common stock issued for settlement of RSUs294,256295(295)----
Stock-based compensation--323,539---323,539
Tax withholdings paid related to stock-based compensation--(15,860)---(15,860)
Foreign currency translation---(141,980)--(141,980)
Net loss for the period----(5,821,529)(47,049)(5,868,578)
Balance, September 30, 202492,392,57092,393202,014,277140,272(223,750,970)(1,136,262)(22,640,290)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.